outperform price
st debat whether
enough execut provid
confid mt holder
evrisi thesi updat solid start year
number gener fine put take
benefit diversif balanc
compani tweak low end guidanc rev
ep worri ortho slowdown core knee
came solid hip resurg print cup benefit
provid confid sustain commentari
solid order book mako also encourag thought
spine gener in-linish despit sale forc disrupt
due on-going integr ktwo syk reiter
msd outlook pf spine incl ktwo reaffirm
integr remain track medsurg continu benefit
strong capital-expenditure environ continu
standout need seal deal
comprehens organ beat hear whisper
report temporari product delay
alpha trauma come mid-year time impact
bone cement order softer medic pull forward rev
prior put brake otherwis solid perform
particularli encourag margin execut
re-affirmed rais ep guidanc despit higher
fx hw vs prior guid said debat whether
enough dont know answer given
choppi current environ remain confid
ep slightli mainli due fx tweak org
new pt equat ep
repres tsr reiter outperform rate
top-line organ guidanc rais mid-point
opex control led om beat vs st track
omx
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
trauma extrem spine came vs
st driven product delay trauma albeit msd
spine pf growth full yr reiter
cite disrupt us spine sale forc due ktwo
integr soft neuro power instrument
ahead sonopet iq launch
came light miss st bp albeit
mix impact
rais organ growth strongest
rais fx hw sale ep bp respect
track om expans bp includ acquisit
reiter effect tax rate year
reiter rang adj net earn
robot instal ww us robot global us
us procedur increas y/i mako procedur
mako placement went competit account provid level detail
order book remain robust see continu momentum
us ou grew call robust gain em eu
surg stand-out driven midteen organ instrument would extrapol
full year off-set lsd spine growth
start year
instrument led gain across power tool wast management note sale forc split
endo perform driven novadaq sport med start ship initi unit
integr build inventori support cross train sale forc
reiter msd pf spine growth full year
expect spine deal next month
ortho perform driven knee off-set declin bone cement due order time
trauma face tough comp along delay launch alpha tibia nail system
push mid-yr
origin expect full commerci launch mid-yr
gm impact ad off-set price busi mix medsurg grow faster
ortho
season lowest perform continu expand inventori
fx drop affect ep translat transact
number sell day vs
sell day
medicar
see low probabl implement
ytd cash op mm
mm share repurchas
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin april
analyst william tong alina levchuk vijay kumar primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research
